01.01.70
Another challenger has devised a health monitor that puts a chip into a medicine bottle cap and can be tapped via mobile to ensure patients hit their dosages on time.
Cambridge Stem Cell Systems pitches in with the claim that it will become the major supplier of custom-made human brain neural stem cells and functional neural tissues to academia, biotech and pharmaceutical industries.
Hygenomics will exploit cheap DNA sequencing technology for automated microbial testing – a market worth $3.2bn.
Plays in cost-effective solar power and cheap water battle with e-health and social media ventures in the CUE £1k competition.
Pragmatism screams out of the entry list: Self-Cervix is a safe, home-use cervical smear kit. Using a device similar to a standard tampon, it allows women to take their own cervical cell sample and post it off for both DNA and cytological analysis.
Eighteen million women in the US opt out of cervical screening, citing high costs, discomfort and inconvenience. This product aims to target the market and improve on the competition in terms of user experience and price, cutting front-end expenses with a simple device design.
Source: Business Weekly